Literature DB >> 19146851

Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice.

Woosung Cho1, Albee Messing.   

Abstract

Alexander disease is a fatal leukoencephalopathy caused by dominantly-acting coding mutations in GFAP. Previous work has also implicated elevations in absolute levels of GFAP as central to the pathogenesis of the disease. However, identification of the critical astrocyte functions that are compromised by mis-expression of GFAP has not yet been possible. To provide new tools for investigating the nature of astrocyte dysfunction in Alexander disease, we have established primary astrocyte cultures from two mouse models of Alexander disease, a transgenic that over-expresses wild type human GFAP, and a knock-in at the endogenous mouse locus that mimics a common Alexander disease mutation. We find that mutant GFAP, as well as excess wild type GFAP, promotes formation of cytoplasmic inclusions, disrupts the cytoskeleton, decreases cell proliferation, increases cell death, reduces proteasomal function, and compromises astrocyte resistance to stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19146851      PMCID: PMC2665202          DOI: 10.1016/j.yexcr.2008.12.012

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  60 in total

Review 1.  Apoptosis and keratin intermediate filaments.

Authors:  R G Oshima
Journal:  Cell Death Differ       Date:  2002-05       Impact factor: 15.828

2.  The small heat shock protein alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation.

Authors:  M C Kamradt; F Chen; V L Cryns
Journal:  J Biol Chem       Date:  2001-03-23       Impact factor: 5.157

3.  Proteomic analysis of the reactive phenotype of astrocytes following endothelin-1 exposure.

Authors:  Gregory F Egnaczyk; James D Pomonis; Julie A Schmidt; Scott D Rogers; Christopher Peters; Joseph R Ghilardi; Patrick W Mantyh; John E Maggio
Journal:  Proteomics       Date:  2003-05       Impact factor: 3.984

4.  A keaper and a striker maintain epidermal homeostasis.

Authors:  Thomas M Magin
Journal:  Nat Genet       Date:  2003-11       Impact factor: 38.330

Review 5.  Providing cellular signposts--post-translational modifications of intermediate filaments.

Authors:  Claire L Hyder; Hanna-Mari Pallari; Vitaly Kochin; John E Eriksson
Journal:  FEBS Lett       Date:  2008-05-23       Impact factor: 4.124

6.  p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases.

Authors:  Kurt Zatloukal; Cornelia Stumptner; Andrea Fuchsbichler; Hans Heid; Martina Schnoelzer; Lukas Kenner; Reinhold Kleinert; Marco Prinz; Adriano Aguzzi; Helmut Denk
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

7.  Human bcl-2 gene attenuates the ability of rabbit lens epithelial cells against H2O2-induced apoptosis through down-regulation of the alpha B-crystallin gene.

Authors:  Y W Mao; H Xiang; J Wang; S Korsmeyer; J Reddan; D W Li
Journal:  J Biol Chem       Date:  2001-09-06       Impact factor: 5.157

8.  Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation.

Authors:  Nobunao Wakabayashi; Ken Itoh; Junko Wakabayashi; Hozumi Motohashi; Shuhei Noda; Satoru Takahashi; Sumihisa Imakado; Tomoe Kotsuji; Fujio Otsuka; Dennis R Roop; Takanori Harada; James Douglas Engel; Masayuki Yamamoto
Journal:  Nat Genet       Date:  2003-09-28       Impact factor: 38.330

Review 9.  Alexander disease: putative mechanisms of an astrocytic encephalopathy.

Authors:  C Mignot; O Boespflug-Tanguy; A Gelot; A Dautigny; D Pham-Dinh; D Rodriguez
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

10.  Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease.

Authors:  M Brenner; A B Johnson; O Boespflug-Tanguy; D Rodriguez; J E Goldman; A Messing
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

View more
  24 in total

1.  Drug screening to identify suppressors of GFAP expression.

Authors:  Woosung Cho; Michael Brenner; Noel Peters; Albee Messing
Journal:  Hum Mol Genet       Date:  2010-06-10       Impact factor: 6.150

2.  Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.

Authors:  Yi-Song Chen; Suh-Ciuan Lim; Mei-Hsuan Chen; Roy A Quinlan; Ming-Der Perng
Journal:  Exp Cell Res       Date:  2011-07-02       Impact factor: 3.905

3.  Knockdown of MLC1 in primary astrocytes causes cell vacuolation: a MLC disease cell model.

Authors:  Anna Duarri; Miguel Lopez de Heredia; Xavier Capdevila-Nortes; Margreet C Ridder; Marisol Montolio; Tania López-Hernández; Ilja Boor; Chun-Fu Lien; Tracy Hagemann; Albee Messing; Dariusz C Gorecki; Gert C Scheper; Albert Martínez; Virginia Nunes; Marjo S van der Knaap; Raúl Estévez
Journal:  Neurobiol Dis       Date:  2011-04-03       Impact factor: 5.996

Review 4.  Strategies for treatment in Alexander disease.

Authors:  Albee Messing; Christine M LaPash Daniels; Tracy L Hagemann
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

5.  Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of Alexander disease.

Authors:  Laura R Moody; Gregory A Barrett-Wilt; Michael R Sussman; Albee Messing
Journal:  J Biol Chem       Date:  2017-02-21       Impact factor: 5.157

6.  Alexander disease.

Authors:  Albee Messing; Michael Brenner; Mel B Feany; Maiken Nedergaard; James E Goldman
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

7.  Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.

Authors:  Heather R Minkel; Tooba Z Anwer; Kara M Arps; Michael Brenner; Michelle L Olsen
Journal:  Glia       Date:  2015-07-17       Impact factor: 7.452

8.  Phenotypic conversions of "protoplasmic" to "reactive" astrocytes in Alexander disease.

Authors:  Alexander A Sosunov; Eileen Guilfoyle; Xiaoping Wu; Guy M McKhann; James E Goldman
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

Review 9.  Dysfunctions of neuronal and glial intermediate filaments in disease.

Authors:  Ronald K H Liem; Albee Messing
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

10.  ASTROCYTES: EMERGING STARS IN LEUKODYSTROPHY PATHOGENESIS.

Authors:  Angela Lanciotti; Maria Stefania Brignone; Enrico Bertini; Tamara C Petrucci; Francesca Aloisi; Elena Ambrosini
Journal:  Transl Neurosci       Date:  2013-06-01       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.